PROGRAM 18 November
Part I: Lectures and Matchmaking Sessions
8:30
Coffee/tea – Infomarket
8:55
Welcome and introduction structure of the program
Dr Maarten van Dongen; Director AMR Insights, The Netherlands
Lectures
09:00
The global funding landscape in AMR R&D
Usha Lamichhane; Global AMR R&D Hub, Germany
09:15
Collaborative Research and Innovation methods
Dr Michael Joseph; Brunel University London, UK
09:30
Using DNA analysis to save to the power of antibiotics
Dr Kristina Lagerstedt; CEO 1928 Diagnostics, Sweden
09:45
AMR in CF: living with it and working on it
Candice King; CF AMR Syndicate (online)
10:00
Phage therapy: New solutions to fight antibiotic resistant infections
Philippe Ghem; Vesale Bioscience, Belgium
Matchmaking Program
10:15
Matchmaking sessions round 1
10:30
Coffee / tea – Infomarket
10:30
Matchmaking sessions round 2
10:45
Matchmaking sessions round 3
Part II: Lectures and Matchmaking Sessions
Lectures
11:00
Prevention of Biofilms on Medical Devices will save thousands of lives and billions of Euros
Dr Carl Genberg; CSO N8 Medical, USA
11:15
Dismantling of Biofilms from the inside out with Disperazol
Dr Michael Graz; CEO Biophys LTD
11:30
Inhibiting proliferation of Clostridioides in the Cdi-screen: an in vitro model similating C. difficile infection
Dr Jos van der Vossen; TNO Healthy Living
11:45
Handheld Raman Spectroscopy based, label-free bacteria identification from plated bacteria, positive blood culture and urine in minutes
Eva Rennen; Nostics, The Netherlands
12:00
Fast antimicrobial susceptibility testing of Enterobacterales using the IPAC2 AR
Dr Ellen Van Hileghem; , UC Leuven, Belgium
Matchmaking Program
12:15
Matchmaking sessions round 4
12:30
Buffet lunch – Infomarket
12:30
Matchmaking sessions round 5
12:45
Matchmaking sessions round 6
Part III: Lectures and Matchmaking Sessions
Lectures
13:30
What’s-Zap? Shedding a new light on how to kill microbes without contributing to AMR
Dr Nicolas Loebel; President & CTO Ondine Biomedical, USA & CAN
13:45
How novel plant based anti-microbials can help reduce the use of antibiotics
Dr Richard Thomas; Managing Director Citrox Biosciences, UK
14:00
Omics technologies and AMR analysis
Prof. Jayaseelan Murugaiyan, SRM University-AP and Dr Krishna Kumar Ballamoole, Nitte University Centre for Science Education & Research, India (online)
14:15
Latest results from the Antimicrobial Resistance Research Programme
Martijn van Gerven, MSc; Access to Medicines Foundation, The Netherlands
14:30
JSS Hospital, clinical investigations and AMR
Prof M N Sumana, JSS Hospital and Medical College, Affiliated to JSS Academy of Higher Education and Research, Mysore, India
Matchmaking program
14:45
Matchmaking sessions round 7
15:00
Coffee/tea-Info market
15:00
Matchmaking sessions round 8
15:15
Matchmaking sessions round 9
Forum discussion ‘Towards inclusive, global innovation in AMR’
15:30
Forum discussion ‘Towards inclusive, global innovation in AMR’ led by Dr Maarten van Dongen, AMR Insights
Forum members Dr Michael Joseph, Brunel University; Prof Till Bachmann University of Edinburgh; Dr Heidi Hopkins London School of Hygiene & Tropical Medicine, London; Dr Catrin Moore, St Georges University of London; Martijn van Gerven, Access to Medicines Foundation, Amsterdam
16:15
Closing remarks
Dr Maarten van Dongen; Director AMR Insights, The Netherlands
16:30
Closure Symposium
